Article in Food science & nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
16 authors.
Laura Costa Alves de AraújoResearch Group on Biotechnology and Bioprospecting Applied to Metabolism and Cancer (GEBBAM) Federal University of Grande Dourados Dourados Mato Grosso do Sul Brazil.
Natasha Rios LeiteResearch Group on Biotechnology and Bioprospecting Applied to Metabolism and Cancer (GEBBAM) Federal University of Grande Dourados Dourados Mato Grosso do Sul Brazil.
Paola Dos Santos da RochaResearch Group on Biotechnology and Bioprospecting Applied to Metabolism and Cancer (GEBBAM) Federal University of Grande Dourados Dourados Mato Grosso do Sul Brazil.ORCID https://orcid.org/0000-0003-1019-1202
Alex Santos OliveiraResearch Group on Biotechnology and Bioprospecting Applied to Metabolism and Cancer (GEBBAM) Federal University of Grande Dourados Dourados Mato Grosso do Sul Brazil.ORCID https://orcid.org/0000-0002-2097-6655
Daniel Ferreira LeiteResearch Group on Biotechnology and Bioprospecting Applied to Metabolism and Cancer (GEBBAM) Federal University of Grande Dourados Dourados Mato Grosso do Sul Brazil.ORCID https://orcid.org/0000-0002-9041-4738
Isabella Giunco EstigarribiaResearch Group on Biotechnology and Bioprospecting Applied to Metabolism and Cancer (GEBBAM) Federal University of Grande Dourados Dourados Mato Grosso do Sul Brazil.
Matheus Henrique Franco AlvesResearch Group on Biotechnology and Bioprospecting Applied to Metabolism and Cancer (GEBBAM) Federal University of Grande Dourados Dourados Mato Grosso do Sul Brazil.
Alércio da Silva SoutilhaResearch Group on Biotechnology and Bioprospecting Applied to Metabolism and Cancer (GEBBAM) Federal University of Grande Dourados Dourados Mato Grosso do Sul Brazil.
Helder Freitas Dos SantosResearch Group on Biotechnology and Bioprospecting Applied to Metabolism and Cancer (GEBBAM) Federal University of Grande Dourados Dourados Mato Grosso do Sul Brazil.ORCID https://orcid.org/0000-0001-8167-8056
Debora da Silva BaldiviaResearch Group on Biotechnology and Bioprospecting Applied to Metabolism and Cancer (GEBBAM) Federal University of Grande Dourados Dourados Mato Grosso do Sul Brazil.ORCID https://orcid.org/0000-0002-1122-8479
Nelson Carvalho Farias JuniorResearch Group on Biotechnology and Bioprospecting Applied to Metabolism and Cancer (GEBBAM) Federal University of Grande Dourados Dourados Mato Grosso do Sul Brazil.
Danielle Araujo AgarrayuaResearch Group in Biochemistry and Toxicology in Caenorhabditis elegans Federal University of Pampa Uruguaiana Rio Grande do Sul Brazil.
Daiana Silva de ÁvilaResearch Group in Biochemistry and Toxicology in Caenorhabditis elegans Federal University of Pampa Uruguaiana Rio Grande do Sul Brazil.
Jaqueline Ferreira CamposResearch Group on Biotechnology and Bioprospecting Applied to Metabolism and Cancer (GEBBAM) Federal University of Grande Dourados Dourados Mato Grosso do Sul Brazil.ORCID https://orcid.org/0000-0002-4981-238X
Kely de Picoli SouzaResearch Group on Biotechnology and Bioprospecting Applied to Metabolism and Cancer (GEBBAM) Federal University of Grande Dourados Dourados Mato Grosso do Sul Brazil.ORCID https://orcid.org/0000-0001-5764-2125
Edson Lucas Dos SantosResearch Group on Biotechnology and Bioprospecting Applied to Metabolism and Cancer (GEBBAM) Federal University of Grande Dourados Dourados Mato Grosso do Sul Brazil.ORCID https://orcid.org/0000-0002-6557-7914
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.